Træthed, hypertension og neutropeni er de mest almindelige behandlingsrelaterede bivirkninger af grad 3 maksimal sværhedsgrad og forhøjet lipase er den hyppigste behandlingsrelaterede bivirkning af grad 4 maksimal sværhedsgrad hos patienter med solide tumorer.
Fatigue, hypertension and neutropoenia were the most common treatment-related adverse events of Grade 3 maximum severity and increased lipase was the most frequently occurring treatment-related adverse event of Grade 4 maximum severity in patients with solid tumours.